logo

Shariah compliance overview

Halal

Xeris Biopharma Holdings, Inc. (XERS) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Xeris Biopharma Holdings, Inc.

Xeris Biopharma Holdings, Inc. operates as a biopharmaceutical company, focusing on the development and commercialization of therapeutic solutions for individuals across the fields of endocrinology, neurology, and gastroenterology.

Xeris Biopharma Holdings, Inc. (XERS) operates in the Healthcare sector, in the Biotechnology industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 1.60% (limit 5%), interest-bearing debt is 5.15% (limit 30%) and interest-bearing securities and assets are 15.13% (limit 30%).

If you hold XERS, give 1.60% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
1.60%Limit 5%Pass
Interest-bearing debt
5.15%Limit 30%Pass
Interest-bearing securities and assets
15.13%Limit 30%Pass
Dividend purification
1.60%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Xeris Biopharma Holdings, Inc. (XERS). Current Akinda screening label: Halal.